Annals of Oncology, 1569-8041

Journal

More filtering options
  1. 2019
  2. The role of plasma microseminoprotein-beta in prostate cancer: An observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition

    Smith Byrne, K., Appleby, P. N., Key, T. J., Holmes, M. V., Fensom, G. K., Agudo, A., Ardanaz, E., Boeing, H., Bueno-De-Mesquita, H. B., Chirlaque, M. D., Kaaks, R., Larranãga, N., Palli, D., Perez-Cornago, A., Quirós, J. R., Ricceri, F., Sánchez, M. J., Tagliabue, G., Tsilidis, K. K., Tumino, R. & 5 others, Fortner, R. T., Ferrari, P., Riboli, E., H. Lilja & Travis, R. C., 2019 Jun 1, In : Annals of Oncology. 30, 6, p. 983-989 7 p., mdz121.

    Research output: Contribution to journalArticle

  3. Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

    Sørensen, J. B., Ekman, S., Brustugun, O. T., Horvat, P., Patel, D., Rosenlund, M., Mette Kejs, A., Juarez-Garcia, A., Daumont, M., Lacoin, L., Penrod, J. R., O'Donnell, J. C. & M. Planck, 2019 Apr, In : Annals of Oncology. 30, Suppl 2, p. ii16-ii17

    Research output: Contribution to journalPublished meeting abstract

  4. Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

    Ekman, S., Sørensen, J. B., Brustugun, O. T., Horvat, P., Patel, D., Rosenlund, M., Mette Kejs, A., Juarez-Garcia, A., Daumont, M., Lacoin, L., Penrod, J. R., O'Donnell, J. C. & M. Planck, 2019 Apr, In : Annals of Oncology. 30, Suppl 2, p. ii17 1 p.

    Research output: Contribution to journalPublished meeting abstract

  5. Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients

    Matikas, A., Foukakis, T., Moebus, V., Greil, R., Bengtsson, N. O., Steger, G. G., Untch, M., Johansson, H., Hellström, M., P. Malmström, Gnant, M., Loibl, S. & Bergh, J., 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1, p. 109-114 6 p.

    Research output: Contribution to journalArticle

  6. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., S. Zackrisson & Senkus, E., 2019, In : Annals of Oncology. 30, 8, p. 1194-1220 27 p.

    Research output: Contribution to journalArticle

  7. Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment

    Weibring, K., Nord, C., Ståhl, O., J. Eberhard, Sandberg, K., Johansson, H., Arver, S., A. Giwercman & Cohn-Cedermark, G., 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 604-611 8 p.

    Research output: Contribution to journalArticle

  8. Vitamin B6 catabolism and lung cancer risk: Results from the Lung Cancer Cohort Consortium (LC3)

    Zuo, H., Ueland, P. M., Midttun, Tell, G. S., Fanidi, A., Zheng, W., Shu, X., Xiang, Y., Wu, J., Prentice, R., Pettinger, M., Thomson, C. A., Giles, G. G., Hodge, A., Cai, Q., Blot, W. J., Johansson, M., Hultdin, J., Grankvist, K., Stevens, V. L. & 29 others, McCullough, M. L., Weinstein, S. J., Albanes, D., Ziegler, R. G., Freedman, N. D., Caporaso, N. E., Langhammer, A., Hveem, K., Næss, M., Buring, J. E., Lee, I., Gaziano, J. M., Severi, G., Zhang, X., Stampfer, M. J., Han, J., Zeleniuch-Jacquotte, A., Marchand, L. L., Yuan, J., Wang, R., Koh, W., Gao, Y., U. Ericson, Visvanathan, K., Jones, M. R., Relton, C., Brennan, P., Johansson, M. & Ulvik, A., 2019, In : Annals of Oncology. 30, 3, p. 478-485 8 p.

    Research output: Contribution to journalArticle

  9. 2018
  10. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Casali, P. G. & et al., 2018 Oct 1, In : Annals of Oncology. 29, p. iv68-iv78

    Research output: Contribution to journalArticle

  11. Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers

    Glodzik, D., Purdie, C. A., Rye, I. H., Simpson, P. T., Johan Staaf, Span, P. N., Russnes, H. & Nik-Zainal, S., 2018 Sep 15, In : Annals of Oncology. 30252041.

    Research output: Contribution to journalArticle

  12. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy

    Friedlander, M., Rau, J., Lee, C. K., Meier, W., Lesoin, A., Kim, J. W., Poveda, A., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M. T., Debruyne, P., Bologna, A., Malander, S., Monk, B. J., Petru, E., Calvert, P., Herzog, T. J., Barrett, C. & 1 others, du Bois, A., 2018 Mar 1, In : Annals of Oncology. 29, 3, p. 737-743 7 p., mdx821.

    Research output: Contribution to journalArticle

  13. Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: The RASTEN trial

    Ek, L., E. Gezelius, Bergman, B., P. O. Bendahl, Anderson, H., Sundberg, J., Wallberg, M., Falkmer, U., Verma, S., M. Belting & Swedish Lung Cancer Study Group (SLUSG), 2018 Feb 1, In : Annals of Oncology. 29, 2, p. 398-404

    Research output: Contribution to journalArticle

  14. The genomic grade index predicts postoperative clinical outcome in patients with soft-tissue sarcoma

    Bertucci, F., De Nonneville, A., Finetti, P., Perrot, D., M. Nilbert, Italiano, A., Le Cesne, A., Skubitz, K. M., Blay, J. Y. & Birnbaum, D., 2018 Feb 1, In : Annals of Oncology. 29, 2, p. 459-465

    Research output: Contribution to journalArticle

  15. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

    Kwong, Y. L., Kim, S. J., Tse, E., Oh, S. Y., Kwak, J. Y., Eom, H. S., Do, Y. R., Mun, Y. C., Lee, S. R., Shin, H. J., Suh, C., Chuang, S. S., Lee, Y. S., Lim, S. T., Izutsu, K., Suzuki, R., Relander, T., d'Amore, F., Schmitz, N., Jaccard, A. & 1 others, Kim, W. S., 2018 Jan 1, In : Annals of Oncology. 29, 1, p. 256-263 mdx684.

    Research output: Contribution to journalArticle

  16. Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer

    Loughman, T., Chan-Ju Wang, A., Dynoodt, P., Fender, B., Lopez Ruiz, C., Barron, S., Stapleton, S., O'Leary, D., Fabre, A., Quinn, C., B. Nodin, K. Jirstrom, Bracken, A. & Gallagher, W. M., 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, Suppl. 8, p. viii65

    Research output: Contribution to journalArticle

  17. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Dhooge, C., Eriksson, M. & 32 others, Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., ESMO Guidelines Committee & PaedCan, 2018, In : Annals of Oncology. 29, p. iv79-iv95

    Research output: Contribution to journalArticle

  18. Intermediate prognosis in metastatic germ cell tumors (IPGCT): Outcome and prognostic stratification

    Seidel, C., Daugaard, K. G., Tryakin, A., Necchi, A., Cohn Cedermark, G., Ståhl, O., Hentrich, M., Brito, M., Albany, C., Taza, F., Gerl, A., Oechsle, K., Oing, C. & Bokemeyer, C., 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii325

    Research output: Contribution to journalArticle

  19. 2017
  20. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Hochhaus, A., Saussele, S., Rosti, G., Mahon, F-X., Janssen, J. J. W. M., Hjorth-Hansen, H., J. Richter, Buske, C. & ESMO Guidelines Committee, 2017, In : Annals of Oncology. 28, p. iv41-iv51

    Research output: Contribution to journalArticle

  21. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Dreyling, M., Campo, E., Hermine, O., M. Jerkeman, Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., Ladetto, M. & on behalf of the ESMO Guidelines Committee, 2017, In : Annals of Oncology. 28, p. iv62-iv71

    Research output: Contribution to journalArticle

  22. 2016
  23. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

    Tandstad, T., Ståhl, O., Dahl, O., Haugnes, H. S., Håkansson, U., Karlsdottir, A., Kjellman, A., Langberg, C. W., Laurell, A., Oldenburg, J., Solberg, A., Söderström, K., Stierner, U., Cavallin-Ståhl, E., Wahlqvist, R., Wall, N. & Cohn-Cedermark, G., 2016 Jul 1, In : Annals of Oncology. 27, 7, p. 1299-1304 6 p., mdw164.

    Research output: Contribution to journalArticle

  24. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

    Helga Hagman, Frödin, J-E., Berglund, Å., Sundberg, J., Vestermark, L., Albertsson, M., Fernebro, E. & Anders Johnsson, 2016 Jan, In : Annals of Oncology. 27, 1, p. 140-147

    Research output: Contribution to journalArticle

  25. Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975.

    Boniol, M., Koechlin, A., Świątkowska, B., Sorahan, T., Wellmann, J., Taeger, D., Jakobsson, K., Pira, E., Boffetta, P., La Vecchia, C., Pizot, C. & Boyle, P., 2016, In : Annals of Oncology. 27, 5, p. 933-941

    Research output: Contribution to journalArticle

  26. Health care resource use and costs of cancer-associated thrombosis in Sweden

    Norrlid, H., Holm, M. V., Norlin, J., P. Svensson & Tennvall, G. R., 2016, In : Annals of Oncology. 27, Suppl. 6, p. vi356

    Research output: Contribution to journalArticle

  27. The prostate cancer registry: Patient characteristics, treatments and preliminary outcomes from a large observational study of metastatic castration-resistant prostate cancer (mCRPC)

    Chowdhury, S., Birtle, A. J., A. Bjartell, Costa, L. A. M., Feyerabend, S., Galli, L., Kalinka-Warzocha, E., Kramer, G., Rey, J. P. M., Lumen, N., Matveev, V. B., Paiss, T., Spaeth, D., Antoni, L., Klumper, E., Wapenaar, R. & Lee, E., 2016, In : Annals of Oncology. 27, Suppl. 6, p. vi253

    Research output: Contribution to journalArticle

  28. 2015
  29. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

    Whelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., Calaminus, G., Capra, M., Deffenbaugh, C., Dhooge, C., Eriksson, M., Flanagan, A. M., Gelderblom, H., Goorin, A., Gorlick, R., Gosheger, G. & 21 others, Grimer, R. J., Hall, K. S., Helmke, K., Hogendoorn, P. C., Jundt, G., Kager, L., Kuehne, T., Lau, C., Letson, G. D., Meyer, J., Meyers, P., Morris, C., Mottl, H., Nadel, H., Nagarajan, R., Randall, R. L., Schomberg, P., Schwarz, R., Teot, L. A., Sydes, M. R. & Bernstein, M., 2015, In : Annals of Oncology. 26, 2, p. 407-414

    Research output: Contribution to journalArticle

  30. Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer

    K. E. Aaltonen, Graffman, C., Larsson, A. M. & L. Rydén, 2015, In : Annals of Oncology. 26, Suppl. 3, p. iii15

    Research output: Contribution to journalArticle

  31. Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

    Tobin, N. P., Harrell, J. C., Lovrot, J., Egyhazi Brage, S., Frostvik Stolt, M., Carlsson, L., Einbeigi, Z., Linderholm, B., Niklas Loman, Malmberg, M., Walz, T., Mårten Fernö, Perou, C. M., Bergh, J., Hatschek, T. & Lindstrom, L. S., 2015, In : Annals of Oncology. 26, 1, p. 81-88

    Research output: Contribution to journalArticle

  32. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., Sophia Zackrisson & Cardoso, F., 2015, In : Annals of Oncology. 26, p. V8-V30

    Research output: Contribution to journalArticle

  33. 2014
  34. 32p * biomarkers and molecular subtypes in primary breast tumors and metastases: associations with liver metastases and outcome.

    Siker Kimbung, Kovács, A., Johansson, I., Danielsson, A., Pär-Ola Bendahl, Einbeigi, Z., Mårten Fernö, Hatschek, T. & Ingrid Hedenfalk, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i11-i12

    Research output: Contribution to journalArticle

  35. 37p * androgen receptor expression in a population-based prospective breast cancer cohort.

    Karin Elebro, Signe Borgquist, Simonsson, M., Markkula, A., Rose, C., Christian Ingvar & Helena Jernström, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i13

    Research output: Contribution to journalPublished meeting abstract

  36. Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

    Mikael Eriksson & The ESMO/European Sarcoma Network Working Group, 2014, In : Annals of Oncology. 25, p. iii113-iii123

    Research output: Contribution to journalArticle

  37. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype

    Fallah, M., Liu, X., Jianguang Ji, Asta Försti, Kristina Sundquist & Kari Hemminki, 2014, In : Annals of Oncology. 25, 7, p. 1397-1404

    Research output: Contribution to journalArticle

  38. One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.

    Tandstad, T., Ståhl, O., Håkansson, U., Dahl, O., Haugnes, H. S., Klepp, O. H., Langberg, C. W., Laurell, A., Oldenburg, J., Solberg, A., Söderström, K., Cavallin-Ståhl, E., Stierner, U., Wahlquist, R., Wall, N. & Cohn-Cedermark, G., 2014, In : Annals of Oncology. 25, 11, p. 2167-2172

    Research output: Contribution to journalArticle

  39. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

    Bonnefoi, H., Litiere, S., Piccart, M., MacGrogan, G., Fumoleau, P., Brain, E., Petit, T., Rouanet, P., Jassem, J., Moldovan, C., Bodmer, A., Zaman, K., Cufer, T., Campone, M., Luporsi, E., Per Malmström, Werutsky, G., Bogaerts, J., Bergh, J. & Cameron, D. A., 2014, In : Annals of Oncology. 25, 6, p. 1128-1136

    Research output: Contribution to journalArticle

  40. Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals Oncology Jan;25(1): 9-15, 2014).

    Valentini, V., Abrahamsson, P-A., Aranda, S. K., Astier, A., Audisio, R. A., Boniol, M., Bonomo, L., Brunelli, A., Bultz, B., Chiti, A., De Lorenzo, F., Eriksen, J. G., Goh, V., Gospodarowicz, M. K., Grassi, L., Kelly, J., Kortmann, R. D., Kutluk, T., Plate, A., Poston, G. & 7 others, Saarto, T., Soffietti, R., Torresin, A., van Harten, W. H., Verzijlbergen, J. F., von Kalle, C. & Poortmans, P., 2014, In : Annals of Oncology. 25, 9, p. 1863-1865

    Research output: Contribution to journalLetter

  41. 2013
  42. A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.

    Anders Johnsson, Helga Hagman, Frödin, J-E., Berglund, Å., Keldsen, N., Fernebro, E., Sundberg, J., De Pont Christensen, R., Garm Spindler, K-L., Bergström, D. & Jakobsen, A., 2013, In : Annals of Oncology. 24, 9, p. 2335-2341

    Research output: Contribution to journalArticle

  43. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC)

    Fedirko, V., Trichopolou, A., Bamia, C., Duarte-Salles, T., Trepo, E., Aleksandrova, K., Noethlings, U., Lukanova, A., Lagiou, P., Boffetta, P., Trichopoulos, D., Katzke, V. A., Overvad, K., Tjonneland, A., Hansen, L., Boutron-Ruault, M. C., Fagherazzi, G., Bastide, N., Panico, S., Grioni, S. & 24 others, Vineis, P., Palli, D., Tumino, R., Bueno-de-Mesquita, H. B., Peeters, P. H., Skeie, G., Engeset, D., Parr, C. L., Jakszyn, P., Sanchez, M. J., Barricarte, A., Amiano, P., Chirlaque, M., Quiros, J. R., Sund, M., Werner, M., Emily Sonestedt, Ulrika Ericson, Key, T. J., Khaw, K. T., Ferrari, P., Romieu, I., Riboli, E. & Jenab, M., 2013, In : Annals of Oncology. 24, 8, p. 2166-2173

    Research output: Contribution to journalArticle

  44. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort

    Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trepo, E., Overvad, K., Roswall, N., Tjonneland, A., Boutron-Ruault, M. C., Fagherazzi, G., Racine, A., Kaaks, R., Grote, V. A., Boeing, H., Trichopoulou, A., Pantzalis, M., Kritikou, M., Mattiello, A., Sieri, S. & 21 others, Sacerdote, C., Palli, D., Tumino, R., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Quiros, J. R., Zamora-Ros, R., Sanchez, M. J., Arriola, L., Ardanaz, E., Tormo, M. J., Peter Nilsson, Lindkvist, B., Sund, M., Rolandsson, O., Khaw, K. T., Wareham, N., Travis, R. C., Riboli, E. & Noethlings, U., 2013, In : Annals of Oncology. 24, 9, p. 2449-2455

    Research output: Contribution to journalArticle

  45. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Obon-Santacana, M., Slimani, N., Lujan-Barroso, L., Travier, N., Hallmans, G., Freisling, H., Ferrari, P., Boutron-Ruault, M. C., Racine, A., Clavel, F., Saieva, C., Pala, V., Tumino, R., Mattiello, A., Vineis, P., Argueelles, M., Ardanaz, E., Amiano, P., Navarro, C., Sanchez, M. J. & 24 others, Montes, E. M., Key, T., Khaw, K. -T., Wareham, N., Peeters, P. H., Trichopoulou, A., Bamia, C., Trichopoulos, D., Boeing, H., Kaaks, R., Katzke, V., Ye, W., Sund, M., Ulrika Ericson, Elisabet Wirfält, Overvad, K., Tjonneland, A., Olsen, A., Skeie, G., Asli, L. A., Weiderpass, E., Riboli, E., Bueno-De-Mesquita, H. B. & Duell, E. J., 2013, In : Annals of Oncology. 24, 10, p. 2645-2651

    Research output: Contribution to journalArticle

  46. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

    Holte, H., Leppa, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M. -L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Janes, R., Pedersen, L. M., Anderson, H., Mats Jerkeman & Mikael Eriksson, 2013, In : Annals of Oncology. 24, 5, p. 1385-1392

    Research output: Contribution to journalArticle

  47. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.

    Wästerlid, T., Brown, P. N., Oskar Hagberg, Hagberg, H., Pedersen, L. M., D'Amore, F. & Mats Jerkeman, 2013, In : Annals of Oncology. 24, 7, p. 1879-1886

    Research output: Contribution to journalArticle

  48. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

    Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Ståhl, E., Clarke, N. W., Classen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K. & 39 others, Flechon, A., Fossa, S. D., Germa Lluch, J. R., Gietema, J. A., Gillessen, S., Aleksander Giwercman, Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C. & Wittekind, C., 2013, In : Annals of Oncology. 24, 4, p. 878-888

    Research output: Contribution to journalReview article

  49. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Sophia Zackrisson & Cardoso, F., 2013, In : Annals of Oncology. 24, p. 7-23

    Research output: Contribution to journalArticle

  50. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Alkner, S., Bendahl, P., Grabau, D., Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In : Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  51. 2012
  52. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled study

    Enblom, A., Anna Johnsson, Hammar, M., Onelov, E., Steineck, G. & Borjeson, S., 2012, In : Annals of Oncology. 23, 5, p. 1353-1361

    Research output: Contribution to journalArticle

  53. Adjuvant therapy in primary GIST: state-of-the-art

    Reichardt, P., Blay, J. -Y., Boukovinas, I., Brodowicz, T., Broto, J. M., Casali, P. G., Decatris, M., Mikael Eriksson, Gelderblom, H., Kosmidis, P., Le Cesne, A., Pousa, A. L., Schlemmer, M., Verweij, J. & Joensuu, H., 2012, In : Annals of Oncology. 23, 11, p. 2776-2781

    Research output: Contribution to journalReview article

  54. Autoimmune disease and subsequent digestive tract cancer by histology

    Kari Hemminki, Liu, X., Jianguang Ji, Jan Sundquist & Kristina Sundquist, 2012, In : Annals of Oncology. 23, 4, p. 927-U6

    Research output: Contribution to journalArticle

  55. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?

    Kari Hemminki, Bevier, M., Jan Sundquist & Hemminki, A., 2012, In : Annals of Oncology. 23, 10, p. 2720-2724

    Research output: Contribution to journalArticle

  56. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

    Schmitz, N., Zeynalova, S., Glass, B., Kaiser, U., Cavallin-Ståhl, E., Wolf, M., Haenel, M., Loeffler, M., Truemper, L. & Pfreundschuh, M., 2012, In : Annals of Oncology. 23, 5, p. 1267-1273

    Research output: Contribution to journalArticle

  57. Death causes in breast cancer patients

    Riihimaeki, M., Thomsen, H., Brandt, A., Jan Sundquist & Kari Hemminki, 2012, In : Annals of Oncology. 23, 3, p. 604

    Research output: Contribution to journalArticle

  58. First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG

    Lindemann, K., Christensen, R. D., Vergote, I., Stuart, G., Izquierdo, M. A., Kaem, J., Havsteen, H., Eisenhauer, E., Ridderheim, M., Lopez, A. B., Hirte, H., Aavall-Lundquvist, E., Vrdoljak, E., Green, J. & Kristensen, G. B., 2012, In : Annals of Oncology. 23, 10, p. 2613-U31

    Research output: Contribution to journalArticle

  59. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project

    Gonzalez, C. A., Megraud, F., Buissonniere, A., Lujan Barroso, L., Agudo, A., Duell, E. J., Boutron-Ruault, M. C., Clavel-Chapelon, F., Palli, D., Krogh, V., Mattiello, A., Tumino, R., Sacerdote, C., Quiros, J. R., Sanchez-Cantalejo, E., Navarro, C., Barricarte, A., Dorronsoro, M., Khaw, K. -T., Wareham, N. & 31 others, Allen, N. E., Tsilidis, K. K., Bueno-de-Mesquita, H. B., Jeurnink, S. M., Numans, M. E., Peeters, P. H. M., Lagiou, P., Valanou, E., Trichopoulou, A., Kaaks, R., Lukanova-McGregor, A., Bergman, M. M., Boeing, H., Jonas Manjer, Lindkvist, B., Stenling, R., Hallmans, G., Mortensen, L. M., Overvad, K., Olsen, A., Tjonneland, A., Bakken, K., Dumeaux, V., Lund, E., Jenab, M., Romieu, I., Michaud, D., Mouw, T., Carneiro, F., Fenge, C. & Riboli, E., 2012, In : Annals of Oncology. 23, 5, p. 1320-1324

    Research output: Contribution to journalArticle

  60. Power and limits of modern cancer diagnostics: cancer of unknown primary

    Kari Hemminki, Liu, H., Heminki, A. & Jan Sundquist, 2012, In : Annals of Oncology. 23, 3, p. 760-764

    Research output: Contribution to journalArticle

  61. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation

    Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., Gandola, L., Mikael Eriksson, Ruggieri, P., Daolio, P., Lindholm, P., Prete, A., Bisogno, G., Tamburini, A., Grignani, G., Abate, M. E., Podda, M., Smeland, S. & Ferrari, S., 2012, In : Annals of Oncology. 23, 11, p. 2970-2976

    Research output: Contribution to journalArticle

  62. Survival in cancer of unknown primary site: population-based analysis by site and histology

    Kari Hemminki, Bevier, M., Hemminki, A. & Jan Sundquist, 2012, In : Annals of Oncology. 23, 7, p. 1854-1863

    Research output: Contribution to journalArticle

  63. 2011
  64. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can)

    Nagel, G., Concin, H., Bjorge, T., Rapp, K., Jonas Manjer, Hallmans, G., Diem, G., Haggstrom, C., Engeland, A., Martin Almquist, Jonsson, H., Selmer, R., T. Stocks, Tretli, S., Ulmer, H., Stattin, P. & Lukanova, A., 2011, In : Annals of Oncology. 22, 6, p. 1339-1345

    Research output: Contribution to journalArticle

  65. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

    Ferrari, S., Hall, K. S., Luksch, R., Tienghi, A., Thomas Wiebe, Fagioli, F., Thor Alvegård, del Prever, A. B., Tamburini, A., Alberghini, M., Gandola, L., Mercuri, M., Capanna, R., Mapelli, S., Prete, A., Carli, M., Picci, P., Barbieri, E., Bacci, G. & Smeland, S., 2011, In : Annals of Oncology. 22, 5, p. 1221-1227

    Research output: Contribution to journalArticle

  66. 2010
  67. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  68. Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours

    Blay, J., Le Cesne, A., Judson, I., Schoffski, P., Sessa, C., Paz-Ares, L., Thomas Högberg, Zintl, P., Parekh, T. V. & Demetri, G. D., 2010, In : Annals of Oncology. 21, Suppl. 8, p. 177-178

    Research output: Contribution to journalPublished meeting abstract

  69. Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

    O'Day, S. J., Maio, M., Chiarion-Sileni, V., Gajewski, T. F., Pehamberger, H., Bondarenko, I. N., Queirolo, P., Lundgren, L., Mikhailov, S., Roman, L., Verschraegen, C., Humphrey, R., Ibrahim, R., de Pril, V., Hoos, A. & Wolchok, J. D., 2010, In : Annals of Oncology. 21, 8, p. 1712-1717

    Research output: Contribution to journalArticle

  70. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

    Tandstad, T., Cohn-Cedermark, G., Dahl, O., Stierner, U., Cavallin-Ståhl, E., Bremnes, R. M. & Klepp, O., 2010, In : Annals of Oncology. 21, 9, p. 1858-1863

    Research output: Contribution to journalArticle

  71. Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma

    Morschhauser, F., Marlton, P., Vitolo, U., Lindén, O., Seymour, J. F., Crump, M., Coiffier, B., Foa, R., Wassner, E., Burger, H. -U., Brennan, B. & Mendila, M., 2010, In : Annals of Oncology. 21, 9, p. 1870-1876

    Research output: Contribution to journalArticle

  72. Second cancers after testicular cancer diagnosed after 1980 in Sweden

    Kari Hemminki, Liu, H. & Jan Sundquist, 2010, In : Annals of Oncology. 21, 7, p. 1546-1551

    Research output: Contribution to journalArticle

  73. STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE

    Ostman, A., Paulsson, J., Liu, T., Lisa Rydén, Karin Jirström, Landberg, G. & Bergh, J., 2010, In : Annals of Oncology. 21, p. 115P

    Research output: Contribution to journalPublished meeting abstract

  74. Vandetanib In Locally Advanced Or Metastatic Differentiated Thyroid Cancer (Papillary Or Follicular; Dtc): A Randomized, Double-Blind Phase Ii Trial

    Leboulleux, S., Bastholt, L., Krause, T. M., De La Fouchardiere, C., Jan Tennvall, Awada, A., Gomez, J. M., Carrasco, A. T., Licour, M. & Schlumberger, M. J., 2010, In : Annals of Oncology. 21, p. 315-315

    Research output: Contribution to journalPublished meeting abstract

  75. 2009
  76. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden

    J. Ji, Shu, X., Li, X., Kristina Sundquist, Sundquist, J. & Hemminki, K., 2009, In : Annals of Oncology. 20, 6, p. 1121-1126

    Research output: Contribution to journalArticle

  77. DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT

    Dolan, R. T., Brennan, D. J., Rexhepaj, E., Kelly, C. M., Penny, S., Karin Jirström, Ponten, F., Uhlen, M. & Gallagher, W. M., 2009, In : Annals of Oncology. 20, Suppl 2, p. 54-54

    Research output: Contribution to journalPublished meeting abstract

  78. Empirically derived psychosocial states among adolescents diagnosed with cancer during the acute and extended phase of survival

    Mattsson, E., El-Khouri, B., Ljungman, G. & von Essen, L., 2009, In : Annals of Oncology. 20, 10, p. 1722-1727

    Research output: Contribution to journalArticle

  79. IDENTIFICATION OF NOVEL SECRETED TUMOR STROMA-DERIVED STIMULATORS OF PROSTATE CANCER GROWTH

    Ostman, A., Augsten, M., Hagglof, C., Bruzzese, F., Leone, A., Olsson, E., Åke Borg, Egevad, L. & Micke, P., 2009, In : Annals of Oncology. 20, Suppl 3, p. O34-O34

    Research output: Contribution to journalPublished meeting abstract

  80. 2008
  81. a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma

    Dueland, S., Aamdal, S., Nyakas, M., Lundgren, L., Wagenius, G., Ljuslinder, I., Stierner, U., Gaullier, J., Nilsson, B. I. & Rasch, W., 2008, In : Annals of Oncology. 19, p. 245-246

    Research output: Contribution to journalPublished meeting abstract

  82. A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

    Glimelius, B., Sorbye, H., Balteskard, L., Bystrom, P., Pfeiffer, P., Tveit, K., Heikkila, R., Keldsen, N., Albertsson, M., Starkhammar, H., Garmo, H. & Berglund, A., 2008, In : Annals of Oncology. 19, 5, p. 909-914

    Research output: Contribution to journalArticle

  83. BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas

    Nyman, H., Mats Jerkeman, Karjalainen-Lindsberg, M., Banham, A., Enblad, G. & Leppa, S., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 142-iv 142

    Research output: Contribution to journalPublished meeting abstract

  84. Burkitt's lymphoma: Comparison of 2 nationwide population-based lymphoma registries

    Brown, P. D., Samuelsson, V., d'Amore, F., Lindh, J., Hagberg, H., Nilsson, G., Bernell, P., Pedersen, L. M. & Mats Jerkeman, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 131-iv 131

    Research output: Contribution to journalPublished meeting abstract

  85. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)

    Crusius, J. B. A., Canzian, F., Capella, G., Pena, A. S., Pera, G., Sala, N., Agudo, A., Rico, F., Del Giudice, G., Palli, D., Plebani, M., Boeing, H., Bueno-de-Mesquita, H. B., Carneiro, F., Pala, V., Save, V. E., Vineis, P., Tumino, R., Panico, S., Berglund, G. & 27 others, Manjer, J., Stenling, R., Hallmans, G., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., Key, T. J., Binghan, S., Caldas, C., Linseisen, J., Kaaks, R., Overvad, K., Tjonneland, A., Buechner, F. C., Peeters, P. H. M., Numans, M. E., Clavel-Chapelon, F., Trichopoulou, A., Lund, E., Jenab, M., Rinaldi, S., Ferrari, P., Riboli, E. & Gonzalez, C. A., 2008, In : Annals of Oncology. 19, 11, p. 1894-1902

    Research output: Contribution to journalArticle

  86. Familial characteristics of Waldenström's macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL): A population-based study in Sweden

    Kristinsson, S. Y., Bjorkholm, M., Goldin, L. R., McMaster, M. L., Ingemar Turesson & Landgren, O., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 166-iv 166

    Research output: Contribution to journalPublished meeting abstract

  87. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

    Aapro, M., Abrahamsson, P-A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G. N., Jonat, W., Lipton, A., Monnier, A., Paterson, A. H. G., Rizzoli, R., Saad, F. & Thürlimann, B., 2008, In : Annals of Oncology. 19, 3, p. 420-432

    Research output: Contribution to journalArticle

  88. Mature T-cell lymphoma patients show high relapse rates after high dose therapy followed by autologous transplantation

    Nickelsen, M., Canals, C., Schmitz, N., Glass, B., Leyvraz, S., Engelhard, M., Koza, V., Relander, T., Holowiecki, J., Linkesch, W., Losonczy, H., Meloni, G., Briones, J. & Sureda, A., 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 113-iv 114

    Research output: Contribution to journalPublished meeting abstract

  89. Nordic Observational Study Evaluating Safety And Analgesic Use In Patients With Advanced Cancer Under Zoledronic Acid Treatment Interim Analysis

    Lindman, H., Ostri, P., Andersen, M., Hagen, E. K., Wiklund, K. & Abrahamsson, P-A., 2008, In : Annals of Oncology. 19, p. 255-255

    Research output: Contribution to journalPublished meeting abstract

  90. Self-selection in sigmoidoscopy screening: A nine-year follow-up study

    Blom, J., Yin, L., Liden, A., Dolk, A., Bengt Jeppsson, Pahlman, L., Holmberg, L. & Nyren, O., 2008, In : Annals of Oncology. 19, Suppl. 6, p. 101-102

    Research output: Contribution to journalPublished meeting abstract

Previous 1 2 Next